comparemela.com

Latest Breaking News On - Helena strig - Page 1 : comparemela.com

NorthX Biologics Welcomes Dr Janet Hoogstraate as New CEO Following Merger with Valneva Clinical Trials Manufacturing Unit

NorthX Biologics Welcomes Dr Janet Hoogstraate as New CEO Following Merger with Valneva Clinical Trials Manufacturing Unit
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

NorthX Biologics, a leading Nordic development and manufacturing organisation announces acquisition of a biologics manufacturing unit from Valneva

NorthX Biologics, a leading Nordic development and manufacturing organisation announces acquisition of a biologics manufacturing unit from Valneva
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Mendus AB: Mendus and NorthX Biologics to enter into strategic cell therapy manufacturing alliance supported by new investor Flerie

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announces that it has entered into a manufacturing alliance with NorthX Biologics AB . NorthX is a. | June 8, 2023

Column: Authentic leadership and clear mandates pave the way for more female CEOs

I believe that the aspect of having clear mandates and titles on the one hand and women progressing into top positions must be explored further, Helena Strigård writes in a column.

Apoglyx, Respinor and RetinaRisk Announced as NLSInvest Rising Star Award Winners

Apoglyx, Respinor and RetinaRisk Announced as NLSInvest Rising Star Award Winners Apoglyx, Respinor and RetinaRisk Announced as NLSInvest Rising Star Award Winners   Pressmeddelande 2021-04-20 08:01 Sigurbjörg Ásta Jónsdóttir, CEO of RetinaRisk (Iceland), Michael Rützler, CEO of Apoglyx (Sweden) and Trude Tingvoll, CEO of Respinor (Norway). Over 150 Nordic companies applied to the launch of the first-ever Nordic Life Science Investment Day, NLSInvest. Following a long review of the applications by a pan-Nordic committee of industry leaders, 80 Rising Stars were ultimately selected to pitch to investors across three dedicated tracks: biotech/pharma, medtech/diagnostics and digital/e-health.  From the 80 Rising Stars, one company from each track was selected as the category winner. The three winners will be awarded a package prize of 15,000 DKK, two registrations to NLSDays 2022, and one company presentation at the 2022 conference. This year, the

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.